Proposal for a new T-stage classification system for distal cholangiocarcinoma: a 10-institution study from the U.S. Extrahepatic Biliary Malignancy Consortium.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 27506989)

Published in HPB (Oxford) on August 09, 2016

Authors

Lauren M Postlewait¹, Cecilia G Ethun¹, Nina Le¹, Timothy M Pawlik², Stefan Buettner², George Poultsides³, Thuy Tran³, Kamran Idrees⁴, Chelsea A Isom⁴, Ryan C Fields⁵, Bradley Krasnick⁵, Sharon M Weber⁶, Ahmed Salem⁶, Robert C G Martin⁷, Charles Scoggins⁷, Perry Shen⁸, Harveshp D Mogal⁸, Carl Schmidt⁹, Eliza Beal⁹, Ioannis Hatzaras¹⁰, Gerardo Vitiello¹⁰, Kenneth Cardona¹, Shishir K Maithel¹¹

Author Affiliations

1: Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
2: Division of Surgical Oncology, Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.
3: Department of Surgery, Stanford University Medical Center, Stanford, CA, USA.
4: Division of Surgical Oncology, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
5: Department of Surgery, Washington University School of Medicine, St Louis, MO, USA.
6: Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
7: Division of Surgical Oncology, Department of Surgery, University of Louisville, Louisville, KY, USA.
8: Department of Surgery, Wake Forest University, Winston-Salem, NC, USA.
9: Division of Surgical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
10: Department of Surgery, New York University, New York, NY, USA.
11: Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA. Electronic address: smaithe@emory.edu.

Articles cited by this ↗

Cancer statistics, 2016. CA Cancer J Clin (2016) 32.95

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med (2010) 15.71

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg (2007) 3.73

Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol (2012) 3.56

Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys (2007) 1.31

Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement. Semin Diagn Pathol (2012) 1.23

Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma. Surgery (2009) 1.11

Distal bile duct carcinoma: prognostic factors after curative surgery. A series of 112 cases. Ann Surg Oncol (2006) 0.94

Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Br J Surg (2015) 0.92

The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy? HPB (Oxford) (2011) 0.92

Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion. Surg Today (2014) 0.89

Experience with distal bile duct cancers in U.S. Veterans Affairs hospitals: 1987-1991. J Surg Oncol (1997) 0.89

Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2-≤4, pT3: >4 cm) is More Valid and Clinically Relevant. Ann Surg Oncol (2016) 0.88

Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases. Ann Surg Oncol (2012) 0.88

Cholangiocarcinoma: are North American surgical outcomes optimal? J Am Coll Surg (2012) 0.88

Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial. BMC Cancer (2015) 0.84

Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors? Eur J Surg Oncol (2015) 0.84

Prognostic factors in patients with middle and distal bile duct cancers. World J Gastroenterol (2014) 0.83

Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors. Asian J Surg (2015) 0.83

Prognostic Accuracy of the Seventh Edition of the TNM Classification Compared with the Fifth and Sixth Edition for Distal Cholangiocarcinoma. Ann Surg Oncol (2015) 0.81

The true prognosis of resected distal cholangiocarcinoma. J Surg Oncol (2016) 0.79

Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up. Langenbecks Arch Surg (2015) 0.79

Articles by these authors ⇆

Is Linitis Plastica a Contraindication for Surgical Resection: A Multi-Institution Study of the U.S. Gastric Cancer Collaborative. Ann Surg Oncol (2015) 0.86

Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the U.S. Gastric Cancer Collaborative. Ann Surg Oncol (2016) 0.85

Irreversible electroporation of locally advanced pancreatic neck/body adenocarcinoma. J Gastrointest Oncol (2015) 0.82

Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease. Ann Surg Oncol (2013) 0.82

A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol (2016) 0.81

The relationship of blood transfusion with peri-operative and long-term outcomes after major hepatectomy for metastatic colorectal cancer: a multi-institutional study of 456 patients. HPB (Oxford) (2015) 0.77

Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium. HPB (Oxford) (2016) 0.77

The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma. Ann Surg Oncol (2015) 0.77

Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes among Patients with Resected Gallbladder Cancer: A Multi-institutional Analysis. Ann Surg Oncol (2016) 0.76

Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit? Ann Surg Oncol (2016) 0.75

Preoperative Helicobacter pylori Infection is Associated with Increased Survival After Resection of Gastric Adenocarcinoma. Ann Surg Oncol (2015) 0.75

Conditional probability of long-term survival after resection of hilar cholangiocarcinoma. HPB (Oxford) (2016) 0.75

Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB (Oxford) (2016) 0.75

Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies. J Gastrointest Surg (2017) 0.75

A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma. J Gastrointest Surg (2016) 0.75

A Minimally Invasive Approach for Inguinal Lymphadenectomy in Melanoma and Genitourinary Malignancy: Long-Term Outcomes in an Attempted Randomized Control Trial. Ann Surg Oncol (2017) 0.75

Irreversible electroporation of stage 3 locally advanced pancreatic cancer: optimal technique and outcomes. J Vis Surg (2015) 0.75

Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma. Ann Surg Oncol (2016) 0.75

Assessing Trends in Palliative Surgery for Extrahepatic Biliary Malignancies: A 15-Year Multicenter Study. J Gastrointest Surg (2016) 0.75

Value of Peritoneal Drain Placement After Total Gastrectomy for Gastric Adenocarcinoma: A Multi-institutional Analysis from the US Gastric Cancer Collaborative. Ann Surg Oncol (2015) 0.75

Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer. World J Surg (2017) 0.75

Prognostic Implications of Lymph Node Status for Patients With Gallbladder Cancer: A Multi-Institutional Study. Ann Surg Oncol (2016) 0.75

Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the U.S. Extrahepatic Biliary Malignancy Consortium. HPB (Oxford) (2017) 0.75

Post-hepatectomy hyperbilirubinemia: The point of no return. Am J Surg (2016) 0.75

Case report: MR imaging features of disseminated uterine leiomyosarcoma presenting after hysterectomy with morcellation. Abdom Imaging (2015) 0.75